Efficacy criteria and cholesterol targets for LDL apheresis

This publication has 28 references indexed in Scilit:

• Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
  Nature Reviews Cardiology, 2009
• Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia
  The American Journal of Cardiology, 2008
• Long-Term Safety and Efficacy of Low-Density Lipoprotein Apheresis in Childhood for Homozygous Familial Hypercholesterolemia
  The American Journal of Cardiology, 2008
• Low‐density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow‐up to 21 Years
  Therapeutic Apheresis and Dialysis, 2008
• Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
  Journal of Clinical Apheresis, 2007
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
  Journal of the American College of Cardiology, 2004
• Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia
  Circulation, 2002
• Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
• No evidence for feedback inhibition of hepatic apolipoprotein B (apo B) production after extracorporeal low density lipoprotein precipitation as determined by [I‐¹³C]leucine infusion in normal volunteers
  European Journal of Clinical Investigation, 1993
• PLASMA EXCHANGE FOR HYPERCHOLESTEROLAEMIA
  The Lancet, 1981